Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
This research assesses nemolizumab effectiveness and safety for treatment of severe pruritus in patients with cutaneous T-cell lymphoma.
Authors
- Sasha Stephen
- Chirag Vasavda (ORCID: https://orcid.org/0000-0003-4558-4698)
- Rachel Meltzer (ORCID: https://orcid.org/0000-0002-8694-8956)
- Neda Shahriari (ORCID: https://orcid.org/0000-0001-5813-0113)
- Cecilia A. Larocca (ORCID: https://orcid.org/0000-0002-6756-261X)
- Krithika Nayudu (ORCID: https://orcid.org/0009-0005-0473-3054)
- Thomas Seth Kupper (ORCID: https://orcid.org/0000-0002-4229-2916)
- Steven Chen
- Farrah Buckhoree
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Augusta University (US)
- Massachusetts General Hospital (US)
- Dana-Farber Brigham Cancer Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2026-11-04
- DOI
- https://doi.org/10.1001/jamadermatol.2026.4305
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00